Related Experiment Videos
New insights into steroid resistant asthma
1Department of Pediatrics, National Jewish Medical and Research Center.
Summary
Steroid-resistant asthma involves airway obstruction despite glucocorticoids. Two types exist: Type I, with reversible glucocorticoid receptor (GCR) defects, and Type II, with low GCR numbers, highlighting mechanisms of steroid resistance.
Area of Science:
- Immunology
- Pulmonology
- Molecular Biology
Background:
- Steroid-resistant (SR) asthma affects patients with persistent airway obstruction and immune activation.
- SR asthma is characterized by unresponsiveness to high-dose systemic glucocorticoids.
- Two primary types of SR asthma are recognized: primary and acquired.
Purpose of the Study:
- To differentiate between Type I and Type II SR asthma.
- To elucidate the molecular mechanisms underlying glucocorticoid receptor (GCR) dysfunction in SR asthma.
- To explore the role of cytokines and alternative splicing in SR asthma pathogenesis.
Main Methods:
- Analysis of glucocorticoid receptor (GCR) ligand and DNA binding affinity.
- Investigation of GCR expression levels.
- Cell culture studies involving IL-2 and IL-4 incubation.
- Examination of GCR pre-mRNA splicing and GCRbeta isoform formation.
Main Results:
- Type I SR asthma exhibits reversible GCR defects, influenced by IL-2 and IL-4.
- Type II SR asthma is associated with a constitutive defect and reduced GCR numbers.
- Cytokine-driven alternative splicing may produce a non-functional GCRbeta isoform in Type I SR asthma.
- Increased transcription factor activation and neutrophil recruitment contribute to SR asthma heterogeneity.
Conclusions:
- SR asthma is a heterogeneous condition with distinct underlying molecular mechanisms.
- GCR defects, including alternative splicing and altered expression, are key in SR asthma.
- Understanding these mechanisms is crucial for developing targeted therapies for SR asthma.